{
    "success": true,
    "data": {
        "leverage": false,
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "synthetic",
        "ucits": true,
        "type": "ETF",
        "complex_factors": [
            "Synthetic Replication",
            "Swap Usage",
            "Counterparty Risk",
            "Underlying commodity index complexities (e.g., roll costs, contango/backwardation effects, though not explicitly detailed as a complexity driver for the ETF's structure in the KID)"
        ],
        "classification": "complex",
        "supporting_data": "The fund, while a UCITS ETF (initially presumed non-complex), explicitly states its investment policy involves financial derivative instruments (FDIs) with UBS AG, London Branch ('UBS') as a counterparty. This constitutes synthetic replication, where the performance of the index is 'swapped' from UBS to the Fund. The rules clearly state that if derivatives are integral to achieving the investment objective (as they are here for index replication) or if swap usage is identified, the asset is classified as complex. The Key Investor Information Document (KID) further highlights 'Counterparty risk' as a material risk, noting that 'The Fund's main investments are the FDIs with UBS as counterparty. The failure of UBS to perform under the terms of the FDIs could significantly affect the Fund.' This introduces a layer of risk and opacity (understanding swaps, counterparty risk, and collateral management) that is generally considered difficult for retail investors with basic knowledge to comprehend. ESMA guidance (CESR/09-295, para 7 and 90) reinforces that derivatives are assumed to be complex due to their derived value and added complexity, and are generally excluded from non-complex instruments under MiFID II Article 38. Therefore, the synthetic structure and the inherent counterparty risk overturn the UCITS presumption of non-complexity."
    }
}